Pyridostigmine injection contains benzyl alcohol as a preservative and should not be used in patients with known benzyl alcohol hypersensitivity or in neonates.
Acetylcholine esterase inhibitors such as pyridostigmine offer symptom relief in myasthenia gravis.
Prescription Products Name Dosage Strength Route Labeller Marketing Start Marketing End. Pyridostigmine Mestinon is an oral cholinesterase inhibitor. A governmentally-recognized ID which uniquely identifies the product within its regulatory market. MedDRA and ICD10 ids are provided for adverse effect conditions and symptoms. Anticholinesterase sensitivity may develop for brief or prolonged periods. If you are using the extended-release tablets, take as directed by your doctor, usually 1 to 2 times daily at least 6 hours apart.
Ask your doctor before use if you are taking the following medications:
When corticosteroids are administered exogenously, increases in blood glucose concentrations would be expected thereby decreasing the hypoglycemic effect of antidiabetic agents.
Patients with unprovoked venous thromboembolism are known to be at high risk for recurrence, but the risk of recurrence among those in whom venous thromboembolism was provoked by minor transient or persistent risk factors is less certain.
In both cases, the symptoms abated with reduction or discontinuation of medication.
This medicine passes into breast milk in amounts that are probably too small to be harmful to a nursing infant. It is not known whether pyridostigmine will harm an unborn baby. Be careful if you drive or do anything that requires you to be alert and able to see clearly. Overdose symptoms may include nausea, vomiting, diarrhea, stomach cramps, sweating, blurred vision, drooling, and weak or shallow breathing.
Store at room temperature away from moisture and heat. You may need to stop using the medicine for a short time.